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Abstract
West Nile fever (WNF) and Rift Valley fever (RVF) are emerging diseases causing epidemics outside their natural range of
distribution. West Nile virus (WNV) circulates widely and harmlessly in the old world among birds as amplifying hosts, and
horses and humans as accidental dead-end hosts. Rift Valley fever virus (RVFV) re-emerges periodically in Africa causing
massive outbreaks. In the Maghreb, eco-climatic and entomologic conditions are favourable for WNV and RVFV emergence.
Both viruses are transmitted by mosquitoes belonging to the Culex pipiens complex. We evaluated the ability of different
populations of Cx. pipiens from North Africa to transmit WNV and the avirulent RVFV Clone 13 strain. Mosquitoes collected in
Algeria, Morocco, and Tunisia during the summer 2010 were experimentally infected with WNV and RVFV Clone 13 strain at
titers of 10
7.8 and 10
8.5 plaque forming units/mL, respectively. Disseminated infection and transmission rates were estimated
14–21 days following the exposure to the infectious blood-meal. We show that 14 days after exposure to WNV, all mosquito
st developed a high disseminated infection and were able to excrete infectious saliva. However, only 69.2% of mosquito
strains developed a disseminated infection with RVFV Clone 13 strain, and among them, 77.8% were able to deliver virus
through saliva. Thus, Cx. pipiens from the Maghreb are efficient experimental vectors to transmit WNV and to a lesser extent,
RVFV Clone 13 strain. The epidemiologic importance of our findings should be considered in the light of other parameters
related to mosquito ecology and biology.
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Introduction
West Nile virus (WNV) and Rift Valley fever virus (RVFV) are
two arthropod-borne RNA viruses transmitted mainly by mosqui-
toes. WNV (Flaviviridae family, Flavivirus genus) was first isolated
in Uganda in 1937 [1] and is now the most widely distributed
arbovirus through the world [2]. This virus is maintained and
amplified in nature within an enzootic transmission cycle, among
birds and mosquitoes, whereas humans and mammals including
horses are accidental dead-end hosts (reviewed in [3]). West Nile
fever (WNF) was not of public health concern until its unexpected
emergence outside its native range of distribution. In the early
1990s, outbreaks began to occur more frequently, especially in the
Mediterranean Basin. In the Maghreb, human cases of meningo-
encephalitis with fatalities occurred in Algeria in 1994 [4] and in
Tunisia in 1997 [5] whereas epizootics in horses were reported in
Morocco in 1996 [6]. In the following years, cases were reported
again: in Tunisia in 2003 [7] and 2008 [8] and in Morocco in
2003 and 2010 [9,10] indicating that WNV is still circulating in
the region. RVFV (Phlebovirus genus, Bunyaviridae family), first
identified in Kenya in 1931 [11] was responsible of numerous
outbreaks affecting livestock and occasionally, humans in Sub-
Saharan Africa. The first emergence of Rift Valley fever (RVF)
outside Africa occurred in 2000–2001 in Saudi Arabia and Yemen
[12]. Illegal trading of livestock between RVF-endemic regions
with their bordering countries stresses the risk for RVF emergence
in the Maghreb [13].
WNV and RVFV are transmitted by mosquitoes of the Culex
pipiens complex including Cx. pipiens and Cx. quinquefasciatus which
are ubiquitous mosquitoes in temperate and tropical regions,
respectively. Cx. pipiens is the most widely distributed mosquito
species in the Maghreb [14–17]. In this region, Cx. pipiens presents
different eco-physiological characteristics. In urban areas, most Cx.
pipiens populations colonize underground sites, are autogenous (lay
first batch of eggs without taking a blood-meal), stenogamous
(mate in confined spaces) and anthropophilic (biting preferentially
humans) [18,19]. Anautogenous populations (lay eggs after a blood
meal) were also found in aboveground sites [20,21]. Conversely, in
rural areas, Cx. pipiens is anautogenous, stenogamous, anthro-
pophilic or ornithophilic (biting preferentially birds) [22].
Determining the vectorial parameters influencing pathogen
transmission is a critical step in understanding patterns of
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36757transmission and developing effective control interventions. The
vector competence of Cx. pipiens is poorly defined in North Africa.
In this paper, we show that populations of Cx. pipiens from the




No specific permissions are required for the field activities which
do not involve endangered or protected species. The field sites are
not privately-owned or protected properties. The Institut Pasteur
in Morocco, Algeria and Tunisia are public institutions of health
and scientific research placed under the supervision of the Ministry
of Health. In this frame, they are involved in vector control
Table 1. Characteristic of Culex pipiens sites sampled in Morocco, Algeria and Tunisia.
Country City Habitat Breeding site
Autogenous (AU) or
Anautogenous (AN) Sample
Morocco Casablanca Urban Underground AU M1_AU
AN M1_AN
Mohammedia Suburban Underground AU M2_AU
AN M2_AN
Algeria Timimoune Urban Underground AU A1_AU
AN A1_AN
Chellal Urban Underground AU A2_AU
AN A2_AN
Oued El Ksob Suburban Aboveground AU A3_AU
AN A3_AN
Bechelga Rural Aboveground AU A4_AU
AN A4_AN
Tunisia Tabarka Urban Aboveground AU T1_AU
AN T1_AN
Nefza Rural Aboveground AU T2_AU
AN T2_AN
doi:10.1371/journal.pone.0036757.t001
Figure 1. Localization of Culex pipiens samples collected in 2010 in the Maghreb (Morocco, Algeria and Tunisia).
doi:10.1371/journal.pone.0036757.g001
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permission for access to breeding sites and mosquito collections.
According to European regulations, manipulations of pathogens
belonging to the group 3 (WNV and RVFV) were carried out in
biosafety level (BSL) 3 facilities.
Mosquitoes
Eight populations of Cx. pipiens were sampled in different sites in
Algeria (4), Morocco (2) and Tunisia (2) during summer 2010
(Table 1, Figure 1). Sites were classified according to the habitat
(urban, suburban or rural) and the type of breeding site
(aboveground and underground). The mosquitoes were collected
as larvae and reared until imago stage. Batches of 200 larvae were
reared in pans containing 1 liter of water supplemented with 1–2
of yeast tablets. This standardized rearing procedure allows
obtaining females of similar size, making them likely to take equal
quantities of blood and to ingest a similar number of viral particles.
Placed on cages, adults were fed on 10% sucrose at 2861uC with
80% relative humidity and a 16 h:8 h photoperiod. Females able
to lay eggs without any blood-meal were qualified as autogenous
(AU) and those which required a blood-meal as anautogenous
(AN). Thus from each of the 8 F0 collections, two F1 strains were
obtained: AU and AN (Table 1). F1 adults were tested for their
susceptibility to WNV and RVFV Clone 13 strain. The
parameters of vector competence used for field-collected samples
were defined using the F6 generation established from a sample
collected in Tabarka in 2010 (Tunisia). This strain is adapted to
laboratory conditions and feeds well on artificial blood-meals.
Except cases mentioned above, no significant difference in DIR,
TR and number of infectious particles in saliva was found 14 days
after exposure to a WNV-infectious blood-meal whatever
mosquitoes are autogenous or anautogenous.
Viruses
The WNV strain was isolated from a horse in Camargue
(France) in 2000 [23]. After 4 passages on Vero cells, the WNV
stock was produced on Ae. albopictus cells C6/36 [24]. The RVFV
is the avirulent strain Clone 13 isolated from a human case in
Bangui (Central African Republic) in 1974 [25]. After 8 passages
on Vero cells, the RVFV stock was produced on C6/36 cells. Viral
stocks were stored at 280uC in aliquots until use.
Oral Infections of Mosquitoes
Infection assays were performed with 7 day-old F1 females
which were allowed to feed for 30 min through a pig intestine
membrane covering the base of a glass feeder containing the
blood-virus mixture maintained at 37uC. The infectious meal was
composed of a viral suspension (1:3) diluted in washed rabbit
erythrocytes isolated from arterial blood collected 24 h before the
infection [26]. The ATP was added as a phagostimulant at a final
concentration of 5610
23 M. Virus titer in the blood-meal was at
10
7.8 PFU/mL for WNV and 10
8.5 PFU/mL for RVFV. Fully
Figure 2. Transmission rate and mean titer of infectious viral particles present in saliva of Culex pipiens at different days after
ingestion of an infectious blood-meal containing WNV (A) and RVFV (B). We exposed a Culex pipiens colony, Tabarka (Tunisia) to an
infectious blood-meal containing 10
7.8 PFU/mL of WNV or 10
8.5 PFU/mL of RVFV. At day 3, 6, 9, 14 and 21 post-infection, 20 females were analyzed.
Saliva were collected using the forced salivation technique. After removing wings and legs, the proboscis of mosquitoes was inserted into 20 mL tip
filled with 5 mL of Fetal Bovine Serum (FBS). After 45 min, medium containing the saliva was collected into 45 mL of L15 medium. The number of
infectious particles per saliva was estimated by titration on Vero cells and expressed as log10PFU/saliva. Lines refer to TR and bars to Log10 pfu/saliva.
doi:10.1371/journal.pone.0036757.g002
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maintained with 10% sucrose at 2861uC for 14–21 days.
Saliva Collection
After the incubation period, saliva was collected using the forced
salivation technique. Briefly, mosquitoes were chilled, their wings
and legs removed and the proboscis was inserted into 20 mL tip
filled with 5 mL of Fetal Bovine Serum (FBS). After 45 min,
medium containing the saliva was expelled into 1.5 mL tube
containing 45 mL of Leibovitz L15 medium. For the colony from
Tabarka, saliva was collected at different days: 1, 2, 3, 6, 9, 14 and
21 days after the exposure to the infectious blood-meal.
Virus Titration
The number of infectious particles per saliva was estimated by
titration on Vero cells and expressed as log10PFU/saliva. Briefly,
six-well plates containing confluent monolayers of Vero cells were
infected with serial 10-fold dilutions of virus. Cells were incubated
for four days (WNV) or five days (RVFV) under an overlay
consisting of Dulbecco’s MEM (DMEM), 2% Fetal Bovine Serum,
1% antibiotic-antimycotic mix (Invitrogen, Gibco) and 1% agarose
at 37uC. The lytic plaques were counted after staining with
a solution of crystal violet (0.2% in 10% formaldehyde and 20%
ethanol). The transmission rate (TR) corresponds to the pro-
portion of mosquitoes whose saliva contains infectious viral
particles among mosquitoes presenting a disseminated infection.
Female Status Analyzed by Immunofluorescent Assay
After salivation, females were sacrified and tested for the
presence of WNV and RVFV viruses on their head squashes by
immunofluorescence assay (IFA) [27]. The presence of virus in
head squashes results from the viral dissemination in the hemocele
after passing through the midgut. The disseminated infection rate
(DIR) corresponds to the proportion of mosquitoes with infected
head squashes among tested mosquitoes.
Statistical Analysis
The Fisher’s exact test was used for comparisons of rates (DIR
and TR) and the Kruskall-Wallis test for comparisons of mean
titers of infectious viral particles in saliva using the STATA
software (StataCorp LP, Texas, USA).
Results
Susceptibility to WNV
The colony Cx. pipiens from Tabarka (Tunisia) was firstly tested
to determine the day post-infection (pi) to collect mosquito saliva
and assess TR of field-collected samples (Figure 2A). WNV started
to be detected in the saliva at day 3 pi with a TR of 5% which
increased slightly until day 9 pi. At day 14 pi, 40% of saliva tested
were infected and the number of infectious particles in saliva
reached its maximum (mean 6 standard deviation: 1.961.2
log10PFU). At day 21 pi, TR continued to increase until 80% and
the number of infectious particles started to slightly decrease to
1.760.9 log10PFU. Thus, day 14 pi was considered to estimate
DIR and TR when mosquitoes were challenged with WNV.
Fourteen days after exposure to WNV, all mosquito strains
tested developed a disseminated infection and were able to deliver
virus through saliva (Figure 3). Strains presented DIRs ranging
from 59.1% to 100% (Figure 3A) and TRs varying from 25% to
83.3% (Figure 3B). When comparing autogenous (AU) and
anautogenous (AN) mosquitoes from a same collection site, DIRs
and TRs were comparable (Fisher’s exact test: p.0.05) except for
two strains from Morocco: strain M1 for DIR (Fisher’s exact test:
p=0.02) and strain M2 for TR (Fisher’s exact test: p=0.01). The
number of infectious particles in saliva varied from 1.060.6
log10PFU to 3.5 log10PFU (Figure 3C). When comparing the
number of infectious particles in saliva between AU and AN
mosquitoes from a same collection site, no significant difference
was found (Kruskall-Wallis test: p.0.05).
Susceptibility to RVFV
With the colony Cx. pipiens from Tabarka, RVFV started to be
detected at day 3 pi with a TR of 10% and 1.360.2 log10PFU in
saliva (Figure 2B). TR remained steady until day 14 pi and
reached a maximum of 40% at day 21 pi. The number of
infectious particles was at its highest level at day 6 pi with 1.660.4
log10PFU and decreased from day 9 to day 21 pi. As a compro-
mise, we chose to estimate DIR and TR at day 14 and day 21 pi
when mosquitoes were exposed to RVFV.
Fourteen days after exposure to RVFV, 69.2% (9 strains among
13 tested) of mosquito strains developed a disseminated infection
with DIRs ranging from 6.2% to 38.1% (Figure 4A). Among
strains exhibiting positive DIRs, 77.8% (7/9) of strains had virus
detected in saliva with TRs varying from 10% to 47.1%
(Figure 4B). Thus, two strains, A1_AU and T1_AN were not
capable to get infected saliva after the dissemination of the virus
from the midgut. When available, comparisons between AU and
AN mosquitoes from a same collection site, did not show any
significant difference of DIRs and TRs (Fisher’s exact test:
p.0.05) except for the T1 strain from Tunisia for TR (Fisher’s
exact test: p=0.004). The number of infectious particles in saliva
varied from 0.660.5 log10PFU to 1.760.7 log10PFU (Figure 4C).
Most infectious saliva came from AU mosquitoes.
At day 21 pi, 78.6% (11 strains among 14 tested) of mosquito
strains developed a disseminated infection with DIRs varying from
5% to 36% (Figure 4D). 91% mosquito strains were able to excrete
infectious saliva with TR ranging from 6.2% to 50% (Figure 4E).
When available, comparisons between AU and AN mosquitoes
from a same collection site, did not show any significant difference
of DIRs and TRs (Fisher’s exact test: p.0.05). 85.7% of strains
were capable to deliver infectious particles in saliva with a number
varying from 0.3 log10PFU to 2.4 log10PFU (Figure 4F). Thus,
increasing the extrinsic incubation period from 14 days to 21 days
increased the proportion of mosquito strains with positive DIRs
and TRs. Moreover, the number of infectious viral particles in
saliva increased concomitantly even if not statistically validated
(Wilcoxon rank-sum test: p.0.05). Autogenous mosquitoes were
more capable to ensure the viral dissemination and transmission.
Figure 3. Disseminated infection rate (A), Transmission rate (B) and mean titer of infectious viral particles present in saliva (C) of
Culex pipiens challenged with WNV. F1 mosquitoes (autogenous AU and anautogenous AN) were orally challenged with WNV at a titer of
10
7.8 PFU/mL using an artificial feeding system. After completion of the blood-meal, mosquitoes were maintained in BSL-3 insectaries at 28uC. At day
14 pi, saliva was collected from surviving females using the forced salivation technique. The number of infectious viral particles present in saliva was
estimated by plaque assay on Vero cells. After salivation, females were tested for the presence of WNV on head squashes by IFA. p,0.05, Fisher’s
exact test. In brackets, the number of mosquitoes tested. Error bars show the confidence interval (95%) for DIR and TR, and the standard deviation for
Log10 pfu/saliva.
doi:10.1371/journal.pone.0036757.g003
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at day 14 (A,B and C) and 21 (D,E and F) post-infection with RVFV. F1 mosquitoes (autogenous AU and anautogenous AN) were orally
challenged with RVFV at a titer of 10
8.5 PFU/mL using an artificial feeding system. After completion of the blood-meal, mosquitoes were maintained
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36757At day 14 pi, 61.5% of samples capable to ensure viral
dissemination and transmission were AU mosquitoes and 38.5%
were AN mosquitoes. At day 21 pi, 57.1% of samples able to
ensure dissemination and transmission were AU mosquitoes and
42.9% were AN mosquitoes.
When considering each mosquito strain and comparing the
DIRs estimated 14 days after infection with WNV and RVFV,
significant differences were found with highest DIRs obtained with
WNV (Fisher’s exact test: P,0.05). When analyzing the TRs
estimated 14 days after infection with WNV and RVFV,
significant differences were obtained for 4 strains among 13
(Fisher’s exact test: P,0.05). However, the number of infectious
particles in saliva was not significantly different when examining
each mosquito strain infected with WNV and RVFV (Wilcoxon
rank-sum test: p.0.05).
Discussion
Culex pipiens is the most widely distributed mosquito species in
the Maghreb and is suspected to be involved in WNV and RVFV
transmission. Using experimental infections, we showed that Cx.
pipiens populations collected in Algeria, Morocco and Tunisia were
highly susceptible to infection and readily to transmit WNV and to
a lesser extent, RVFV.
To be transmitted to a vertebrate host, an arbovirus must be
able to reach and infect the salivary glands. After feeding on
a viremic vertebrate host, the ingested virus must penetrate into
the midgut epithelial cells, replicates and subsequently, escape
from the midgut. The virus disseminates within the body cavity
infecting tissues and organs including salivary glands. Infectious
viral particles are injected into a new vertebrate host along with
saliva. Barriers to the overall sequence leading to transmission are
described: the midgut and the salivary glands (reviewed in [28]).
The efficiency of these barriers determines the level of mosquito
vector competence. For both viruses tested, WNV and RVFV, the
time interval between the ingestion of a viremic blood-meal and
the ability of a mosquito to transmit a pathogen, described as the
extrinsic incubation period (EIP) was 3 days with Cx. pipiens from
Tabarka (Tunisia).
When exposed to an infectious blood-meal containing WNV, all
mosquito strains collected in 8 different sites in the Maghreb, were
capable to ensure efficient viral dissemination and transmission at
day 14 pi. Our findings are in line with the predominant role of
Cx. pipiens in the transmission of WNV. DIRs varied from 59% to
100%, and TRs from 25% to 100%. The number of viral particles
delivered with saliva was up to , 12800 particles. Vector
competence is mainly influenced by viral dose, incubation period
and temperature. We used a viral titre of 10
7.8 PFU/mL and an
incubation temperature of 28uC, both factors affecting viral
dissemination [29]. Indeed, the minimal infectious doses required
to infect Cx. pipiens should be greater than 10
5.0 PFU/mL [30] and
high temperatures increase viral replication [31]. Previous studies
have shown spatial variations in WNV vector competence of Cx.
pipiens [32–34]. We also observed geographic variations in vector
competence without assignment of high performances to a given
country or a collection site.
We used for RVFV, the Clone 13 which is a naturally
attenuated strain with a deletion of 70% of the gene NSs playing
a key role in the pathogenesis of RVFV [35,36]. It has been shown
that this deletion could affect viral replication in mosquitoes. It has
been shown that dissemination was higher when exposed
mosquitoes to a virulent RVFV [37]. We found that 14 days
after exposure to RVFV, 69.2% of mosquito strains were able to
develop a disseminated infection with DIRs up to 38.1%, values
higher than those previously found for Cx. pipiens populations from
Tunisia [38] but lower than DIRs for laboratory colonies of Cx.
pipiens [39]. Most strains (77.8%) were able to transmit the virus
with up to , 620 viral particles detected in saliva. The midgut
infection was the most important barrier to viral dissemination
[40]. The moderate ability of Cx. pipiens to transmit RVFV is
mostly due to the inefficiency of virions to escape from midgut
epithelial cells to infect secondary target organs [41]. When
increasing the incubation period up to 21 days, 78.6% of mosquito
strains develop a disseminated infection and 91% were able to
deliver infectious particles in saliva. Thus, Cx. pipiens with
disseminated infection that did not have infectious saliva at day
14 pi may have viral infections to develop a week later [42].
Moreover, the midgut barrier appears to be operating by delaying
the release of the virus into the general cavity of Cx. pipiens infected
with RVFV [41]. A sporadic dissemination of virus from the
midgut was likely to operate rather than a complete blockade of
the virus inside the midgut epithelial cells.
Our strains contain a mix of autogenous (AU) and anautogen-
ous (AN) mosquitoes. The two forms are thought to have different
vector competences (reviewed in [43]). Indeed, we found evidence
that when challenged with RVFV, AU mosquitoes were pre-
dominantly capable to ensure the viral dissemination and trans-
mission, 14 days after the exposure to the infectious blood-meal
(see Figure 4C). Surprisingly, AN mosquitoes were characterized
by a delay in RVFV transmission; AN populations were more
likely to transmit 21 days after feeding on an infectious blood-meal
(see Figure 4F). We suggested that epizootic outbreaks of RVF can
be initiated by Aedes or Ochlerotatus mosquitoes which are present in
high densities in rural areas [14,44,45]. Aedes mosquitoes such as
Ae. vexans in West Africa [46–49] capable to transmit the virus
vertically to their offspring are likely to initiate the virus
circulation. Subsequent epizootic outbreaks are associated with
Culex mosquitoes. Based on their low vector competence, we
hypothesized that AN mosquitoes in rural areas weakly take part
to RVFV transmission. AU mosquitoes are more likely to serve as
a bridge vector between animals and humans. A RVF cycle could
then be initiated when AU mosquitoes reach densities high enough
to trigger an epidemic/epizootic outbreak. The Maghreb region
shares borders with RVF-endemic countries. In 2010, a severe
outbreak has been reported in an extremely arid region of
Mauritania close to borders with Morocco and Algeria [50].
Introduction of infected livestock raised concern for future
emergences of RVF. Indeed, the RVF outbreaks in Egypt in
1977 and in Saudi Arabia in 2000 were caused by the trade of
viremic animals [51,52].
Like WNF, RVF could become epizootic and epidemic in the
Maghreb if introduced. Unless vaccines are available and used on
a very large scale to limit their expansion, both WNF and RVF
will continue to be a critical issue for human and animal health. In
a near future, protection of the public health will continue to rely
on mosquito control. Further studies are required to understand
in BSL-3 insectaries at 28uC. At day 14 pi and day 21 pi, saliva was collected from surviving females using the forced salivation technique. The number
of infectious viral particles present in saliva was estimated by plaque assay on Vero cells. After salivation, females were tested for the presence of
RVFV on head squashes by IFA. In brackets, the number of mosquitoes tested. Error bars show the confidence interval (95%) for DIR and TR, and the
standard deviation for Log10 pfu/saliva.
doi:10.1371/journal.pone.0036757.g004
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Maghreb.
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